Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-11-02

FDA Approved: DIGOXIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for digoxin from Sandoz Inc, resulting in a label change for the generic heart medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)

Snippet

SUPPL AP for DIGOXIN (DIGOXIN)